GMDA logo

Gamida Cell Ltd. (GMDA)

Profile

Full Name

Gamida Cell Ltd.

Ticker Symbol

NASDAQ: GMDA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

October 26, 2018

Indexes

Not included

Website

http://www.gamida-cell.com

Employees

143

Key Details

Price

$0.03

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.78M

Annual EPS

-$0.57(+54.03% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.03
    GMDA price is $0.03

    30-Day Relative Volume

    2.14
    GMDA 30-day relative volume is 2.14

    Price Performance

    Price Most recent change

    -
    GMDA price change on Jun 17, 2025 is unknown

    Price YTD change

    -
    GMDA price ytd change is unknown

    Price 1-year change

    -
    GMDA price 1-year change is unknown

    Price 3-year change

    -98.12%
    GMDA price is down -98.12% over the past 3 years

    Price Range

    Price All-time high

    $15.41
    GMDA price is currently -99.79% below its historical high of $15.41

    Price 3-year low

    $0.01
    GMDA price is currently +308.75% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $5.04M
    GMDA market capitalization is $5.04 million

    Market cap 3-year change

    -95.17%
    GMDA market capitalization is down -95.17% over the past 3 years

    Market cap All-time high

    $733.37M
    GMDA market capitalization is currently -99.31% below its historical high of $733.37 million

    Market cap sector rank

    11.48%
    GMDA market capitalization is higher than 11.48% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    GMDA {parameterFullLabel} has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +156.85%
    GMDA shares outstanding is up +156.85% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.00
    GMDA beta is 0.00

    200-day SMA

    $0.43
    GMDA price is currently -92.42% below its 200-day simple moving average

    50-day SMA

    $0.02
    GMDA price is currently +47.96% above its 50-day simple moving average

    RSI

    48.57
    GMDA 14-day relative strength index is 48.57

    Volume

    2.14
    GMDA 30-day relative volume is 2.14

    ATR

    $0.00
    GMDA average true range is $0.00

    10-day Historical Volatility

    463.59%
    GMDA 10-day historical volatility is 463.59%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.78M
    GMDA annual revenue is $1.78 million

    Revenue Analysts estimate

    $15.68M
    GMDA annual revenue is currently -88.62% lower than the consensus analysts' forecast

    Revenue 1-year change

    -
    GMDA annual revenue 1-year change is unknown

    Revenue Sector rank

    14.5%
    GMDA annual revenue is higher than 14.5% of companies in Healthcare sector

    EPS

    EPS

    -$0.57
    GMDA annual earnings per share is -$0.57

    EPS Analysts estimate

    -$0.57
    GMDA annual earnings per share is currently equal to the consensus analysts' forecast

    EPS 1-year change

    +54.03%
    GMDA annual earnings per share is up +54.03% year-on-year

    EPS Sector rank

    65.62%
    GMDA annual earnings per share is higher than 65.62% of companies in Healthcare sector

    Profit

    Gross profit

    -$3.75M
    GMDA annual gross profit is -$3.75 million

    Gross margin

    -210.26%
    GMDA annual gross profit margin is -210.26%

    Operating profit

    -$72.64M
    GMDA annual operating income is -$72.64 million

    Operating margin

    -4071.92%
    GMDA annual operating profit margin is -4071.92%

    Net income

    -$63.00M
    GMDA annual net profit is -$63.00 million

    Net margin

    -3531.17%
    GMDA annual net profit margin is -3531.17%

    Expenses

    Total expenses

    $74.43M
    GMDA annual total expenses is $74.43 million

    Operating expenses

    $68.89M
    GMDA annual total operating expenses is $68.89 million

    Cost of goods sold

    $5.54M
    GMDA annual cost of goods sold is $5.54 million

    Selling, general & administrative expenses

    $44.58M
    GMDA annual SGA is $44.58 million

    Depreciation and amortization

    $2.02M
    GMDA annual depreciation & amortization is $2.02 million

    Interest expense

    $7.59M
    GMDA annual interest expense is $7.59 million

    Income tax

    -
    GMDA annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$55.41M
    GMDA annual earnings before interest & taxes is -$55.41 million

    EBITDA

    -$53.38M
    GMDA annual EBITDA is -$53.38 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $102.19M
    GMDA annual total assets is $102.19 million

    Non current assets

    $47.64M
    GMDA annual long term assets is $47.64 million

    Current assets

    $54.55M
    GMDA annual total current assets is $54.55 million

    Cash and cash equivalents

    $46.55M
    GMDA annual cash & cash equivalents is $46.55 million

    Accounts receivable

    $1.61M
    GMDA annual accounts receivable is $1.61 million

    Inventory

    $1.91M
    GMDA annual inventory is $1.91 million

    Liabilities

    Total liabilities

    $105.14M
    GMDA annual total liabilities is $105.14 million

    Long term liabilities

    $79.93M
    GMDA annual total long term liabilities is $79.93 million

    Current liabilities

    $25.20M
    GMDA annual total current liabilities is $25.20 million

    Accounts payable

    $1.88M
    GMDA annual accounts payable is $1.88 million

    Debt

    Total debt

    $82.94M
    GMDA annual total debt is $82.94 million

    Total debt 1-year change

    -20.22%
    GMDA annual total debt is down -20.22% year-on-year

    Long term debt

    $75.17M
    GMDA annual long term debt is $75.17 million

    Short term debt

    $7.78M
    GMDA annual short term debt is $7.78 million

    Equity & Capital

    Shareholders equity

    -$2.95M
    GMDA annual stockholders equity is -$2.95 million

    Book value

    -$2.95M
    GMDA annual book value is -$2.95 million

    Retained earnings

    -$479.83M
    GMDA annual retained earnings is -$479.83 million

    Working capital

    $29.34M
    GMDA annual working capital is $29.34 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$79.12M
    GMDA annual cash flow from operations is -$79.12 million

    Cash from operations 1-year change

    -12.35%
    GMDA annual cash flow from operations is down -12.35% year-on-year

    Cash from investing

    -$810.00K
    GMDA annual cash flow from investing activities is -$810.00 thousand

    Cash from investing 1-year change

    -102.38%
    GMDA annual cash flow from investing activities is down -102.38% year-on-year

    Cash from financing

    $61.77M
    GMDA annual cash flow from financing activities is $61.77 million

    Cash from financing 1-year change

    +36.83%
    GMDA annual cash flow from financing activities is up +36.83% year-on-year

    CAPEX

    CAPEX

    $1.08M
    GMDA annual capital expenditures is $1.08 million

    CAPEX 1-year change

    -
    GMDA annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$80.20M
    GMDA annual free cash flow is -$80.20 million

    Free cash flow 1-year change

    -4.46%
    GMDA annual free cash flow is down -4.46% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -210.26%
    GMDA annual gross profit margin is -210.26%

    Operating margin

    -4071.92%
    GMDA annual operating profit margin is -4071.92%

    Net margin

    -3531.17%
    GMDA annual net profit margin is -3531.17%

    ROA & ROE

    ROA

    -61.65%
    GMDA annual return on assets is -61.65%

    ROE

    2136.18%
    GMDA annual return on equity is 2136.18%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    GMDA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    GMDA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.27
    GMDA price to book ratio is -0.27

    PB ratio Sector rank

    12.32%
    GMDA price to book ratio is higher than 12.32% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.88
    GMDA price to sales ratio is 1.88

    PS ratio Sector rank

    38.33%
    GMDA price to sales ratio is higher than 38.33% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $58.35M
    GMDA enterprise value is $58.35 million

    Enterprise value Sector rank

    39.37%
    GMDA enterprise value is higher than 39.37% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.01
    GMDA EV/EBITDA is -1.01

    EV/EBITDA Sector rank

    47.34%
    GMDA EV/EBITDA is higher than 47.34% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.16
    GMDA annual current ratio is 2.16

    Quick ratio

    2.09
    GMDA annual quick ratio is 2.09

    Leverage

    Debt to equity

    -26.97
    GMDA annual debt to equity ratio is -26.97

    Interest coverage ratio

    -7.30
    GMDA annual interest coverage ratio is -7.30

    Risk & Stability

    Piotroski F-Score

    -
    GMDA piotroski f-score value is unknown

    Altman Z-Score

    -7.97
    GMDA altman z-score is -7.97

    Analyst ratings

    Recent major analysts updates

    Jan 29, 24 JMP Securities
    Market Perform
    Dec 5, 23 Needham
    Buy
    Nov 15, 23 Piper Sandler
    Overweight
    Nov 15, 23 HC Wainwright & Co.
    Buy
    Sep 28, 23 JMP Securities
    Market Outperform
    Aug 16, 23 HC Wainwright & Co.
    Buy
    Aug 15, 23 Needham
    Buy
    Jun 30, 23 Needham
    Buy
    May 24, 23 JMP Securities
    Market Outperform
    May 22, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with GMDA included

    Stocks cheaper than 1 dollar
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotechnology industry
    Ex Dividend dates calendar
    • What is the ticker symbol for Gamida Cell Ltd.?
    • Does Gamida Cell Ltd. pay dividends?
    • What sector is Gamida Cell Ltd. in?
    • What industry is Gamida Cell Ltd. in?
    • What country is Gamida Cell Ltd. based in?
    • When did Gamida Cell Ltd. go public?
    • Is Gamida Cell Ltd. in the S&P 500?
    • Is Gamida Cell Ltd. in the NASDAQ 100?
    • Is Gamida Cell Ltd. in the Dow Jones?
    • When was Gamida Cell Ltd.'s last earnings report?
    • When does Gamida Cell Ltd. report earnings?

    What is the ticker symbol for Gamida Cell Ltd.?

    The ticker symbol for Gamida Cell Ltd. is NASDAQ:GMDA

    Does Gamida Cell Ltd. pay dividends?

    No, Gamida Cell Ltd. does not pay dividends

    What sector is Gamida Cell Ltd. in?

    Gamida Cell Ltd. is in the Healthcare sector

    What industry is Gamida Cell Ltd. in?

    Gamida Cell Ltd. is in the Biotechnology industry

    What country is Gamida Cell Ltd. based in?

    Gamida Cell Ltd. is headquartered in Israel

    When did Gamida Cell Ltd. go public?

    Gamida Cell Ltd.'s initial public offering (IPO) was on October 26, 2018

    Is Gamida Cell Ltd. in the S&P 500?

    No, Gamida Cell Ltd. is not included in the S&P 500 index

    Is Gamida Cell Ltd. in the NASDAQ 100?

    No, Gamida Cell Ltd. is not included in the NASDAQ 100 index

    Is Gamida Cell Ltd. in the Dow Jones?

    No, Gamida Cell Ltd. is not included in the Dow Jones index

    When was Gamida Cell Ltd.'s last earnings report?

    Gamida Cell Ltd.'s most recent earnings report was on May 15, 2024

    When does Gamida Cell Ltd. report earnings?

    The date for Gamida Cell Ltd.'s next earnings report has not been announced yet
    On this page